Bruton's tyrosine kinase-an integral protein of B cell development that also has an essential role in the innate immune system

Journal of Leukocyte Biology

Volumn 95, Issue 2, 2014, Pages 243-250

  López Herrera, Gabriela ^a   Vargas Hernández, Alexander ^b   González Serrano, Maria Edith ^a   Berrón Ruiz, Laura ^a   Rodríguez Alba, Juan Carlos ^c   Espinosa Rosales, Francisco ^a   Santos Argumedo, Leopoldo ^b  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSIDAD VERACRUZANA   (Mexico)

Author keywords

Inflammation; TLRs; XLA

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; BRUTON TYROSINE KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN SH3; AGAMMAGLOBULINAEMIA TYROSINE KINASE; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN TYROSINE KINASE;

ACUTE HEPATITIS; AGAMMAGLOBULINEMIA; AMINO ACID SUBSTITUTION; AUTOSOMAL RECESSIVE DISORDER; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CELL; CELL MATURATION; GENE DELETION; GENE INSERTION; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS; MISSENSE MUTATION; MONOCYTE; NEUTROPHIL; NONHUMAN; OSTEOCLAST; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SPLEEN CELL; THROMBOCYTE; THROMBOCYTE RELEASE REACTION; VIRAL CLEARANCE; X CHROMOSOME LINKED DISORDER; ANIMAL; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MUTATION; TLRS; XLA;

INFLAMMATION; TLRS; XLA;

AGAMMAGLOBULINEMIA; ANIMALS; B-LYMPHOCYTES; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNITY, INNATE; MUTATION; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, B-CELL;

EID: 84897096601     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0513307     Document Type: Review

References (89)

1. Bruton, O. C. (1952) Agammaglobulinemia. Pediatrics 9, 722-728.
2. Cooper, M. D., Lawton, A. R. (1972) Circulating B-cells in patients with immunodeficiency. Am. J. Pathol. 69, 513-528.
3. Conley, M. E. (2009) Genetics of hypogammaglobulinemia: what do we really know? Curr. Opin. Immunol. 21, 466-471.
4. Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarstrom, L., Kinnon, C., Levinsky, R., Bobrow, M., Smith, C. I., Bentley, D. R. (1993) The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361, 226-233.
5. Tsukada, S., Saffran, D. C., Rawlings, D. J., Parolini, O., Allen, R. C., Klisak, I., Sparkes, R. S., Kubagawa, H., Mohandas, T., Quan, S., Belmont, J. W. Cooper, M. D., Conley, M. E., Witte, O. N. (1993) Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72, 279-290.
6. De Weers, M., Verschuren, M. C., Kraakman, M. E., Mensink, R. G., Schuurman, R. K., van Dongen, J. J., Hendriks, R. W. (1993) The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur. J. Immunol. 23, 3109-3114.
7. Rawlings, D. J., Saffran, D. C., Tsukada, S., Largaespada, D. A., Grimaldi, J. C., Cohen, L., Mohr, R. N., Bazan, J. F., Howard, M., Copeland, N. G., Jenkins, N. A., Witte, O. N. (1993) Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261, 358-361.
8. Hendriks, R. W., de Bruijn, M. F., Maas, A., Dingjan, G. M., Karis, A., Grosveld, F. (1996) Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J. 15, 4862-4872.
9. Plebani, A., Soresina, A., Rondelli, R., Amato, G. M., Azzari, C., Cardinale, F., Cazzola, G., Consolini, R., De Mattia, D., Dell'Erba, G., Duse, M., Fiorini, M., Martino, S., Martire, B., Masi, M., Monafo, V., Moschese, V., Notarangelo, L. D., Orlandi, P., Panei, P., Pession, A., Pietrogrande, M. C., Pignata, C., Quinti, I., Ragno, V., Rossi, P., Sciotto, A., Stabile, A. (2002) Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin. Immunol. 104, 221-230.
10. Chun, J. K., Lee, T. J., Song, J. W., Linton, J. A., Kim, D. S. (2008) Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance Hospital. Yonsei Med. J. 49, 28-36.
11. Aghamohammadi, A., Fiorini, M., Moin, M., Parvaneh, N., Teimourian, S., Yeganeh, M., Goffi, F., Kanegane, H., Amirzargar, A. A., Pourpak, Z., Rezaei, N., Salavati, A., Pouladi, N., Abdollahzade, S., Notarangelo, L. D., Miyawaki, T., Plebani, A. (2006) Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia. Int. Arch. Allergy Immunol. 141, 408-414.
12. Hashimoto, S., Miyawaki, T., Futatani, T., Kanegane, H., Usui, K., Nukiwa, T., Namiuchi, S., Matsushita, M., Yamadori, T., Suemura, M., Kishimoto, T., Tsukada, S. (1999) Atypical X-linked agammaglobulinemia diagnosed in three adults. Intern. Med. 38, 722-725.
13. Usui, K., Sasahara, Y., Tazawa, R., Hagiwara, K., Tsukada, S., Miyawaki, T., Tsuchiya, S., Nukiwa, T. (2001) Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults. Respir. Res. 2, 188-192.
14. Basile, N., Danielian, S., Oleastro, M., Rosenzweig, S., Prieto, E., Rossi, J., Roy, A., Zelazko, M. (2009) Clinical and molecular analysis of 49 patients with X-linked agammaglobulinemia from a single center in Argentina. J. Clin. Immunol. 29, 123-129.
15. Winkelstein, J. A., Marino, M. C., Lederman, H. M., Jones, S. M., Sullivan, K., Burks, A. W., Conley, M. E., Cunningham-Rundles, C., Ochs, H. D. (2006) X-Linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine 85, 193-202.
16. Toth, B., Volokha, A., Mihas, A., Pac, M., Bernatowska, E., Kondratenko, I., Polyakov, A., Erdos, M., Pasic, S., Bataneant, M., Szaflarska, A., Mironska, K., Richter, D., Stabrik, K., Avcin, T., Márton, G., Nagy, K., Dérfalvi, B., Szolnoky, M., Kalmár, A., Belevtsev, M., Guseva, M., Rugina, A., Kriván, G., Timár, L., Nyui, Z., Mosdósi, B., Kareva, L., Peova, S., Chernyshova, L., Gherghina, I., Serban, M., Conley, M. E., Notarangelo, L. D., Smith, C. I., van Dongen, J., van der Burg, M., Maródi, L. (2009) Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study. Mol. Immunol. 46, 2140-2146.
17. Kanegane, H., Taneichi, H., Nomura, K., Futatani, T., Miyawaki, T. (2005) Severe neutropenia in Japanese patients with X-linked agammaglobulinemia. J. Clin. Immunol. 25, 491-495.
18. Farrar, J. E., Rohrer, J., Conley, M. E. (1996) Neutropenia in X-linked agammaglobulinemia. Clin. Immunol. Immunopathol. 81, 271-276.
19. Lee, P. P., Chen, T. X., Jiang, L. P., Chan, K. W., Yang, W., Lee, B. W., Chiang, W. C., Chen, X. Y., Fok, S. F., Lee, T. L., Ho, M. H., Yang, X. Q., Lau, Y. L. (2010) Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia. J. Clin. Immunol. 30, 121-131.
20. Väliaho, J., Smith, C. I., Vihinen, M. (2006) BTKbase: the mutation database for X-linked agammaglobulinemia. Human Mutat. 27, 1209-1217.
21. Lindvall, J. M., Blomberg, K. E., Valiaho, J., Vargas, L., Heinonen, J. E., Berglof, A., Mohamed, A. J., Nore, B. F., Vihinen, M., Smith, C. I. (2005) Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol. Rev. 203, 200-215.
22. Vargas-Hernandez, A., Lopez-Herrera, G., Maravillas-Montero, J. L., Vences-Catalan, F., Mogica-Martinez, D., Rojo-Dominguez, A., Espinosa-Rosales, F. J., Santos-Argumedo, L. (2012) Consequences of two naturally occurring missense mutations in the structure and function of Bruton agammaglobulinemia tyrosine kinase. IUBMB Life 64, 346-353.
23. Lopez-Herrera, G., Berron-Ruiz, L., Mogica-Martinez, D., Espinosa-Rosales, F., Santos-Argumedo, L. (2008) Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia. Mol. Immunol. 45, 1094-1098.
24. Gonzalez-Serrano, M. E., Estrada-Garcia, I., Mogica-Martinez, D., Gonzalez-Garay, A., Lopez-Herrera, G., Berron-Ruiz, L., Espinosa-Padilla, S. E., Yamazaki-Nakashimada, M. A., Vargas-Hernandez, A., Santos-Argumedo, L., Estrada-Parra, S. A., Espinosa-Rosales, F. J. (2012) Increased pro-inflammatory cytokine production after lipopolysaccharide stimulation in patients with X-linked agammaglobulinemia. J. Clin. Immunol. 32, 967-974.
25. Wang, L. D., Clark, M. R. (2003) B-cell antigen-receptor signalling in lymphocyte development. Immunology 110, 411-420.
26. Goetz, C. A., Harmon, I. R., O'Neil, J. J., Burchill, M. A., Farrar, M. A. (2004) STAT5 activation underlies IL7 receptor-dependent B cell development. J. Immunol. 172, 4770-4778.
27. Peschon, J. J., Morrissey, P. J., Grabstein, K. H., Ramsdell, F. J., Maraskovsky, E., Gliniak, B. C., Park, L. S., Ziegler, S. F., Williams, D. E., Ware, C. B., Meyer, J. D., Davison, B. L. (1994) Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960.
28. Matthews, D. J., Clark, P. A., Herbert, J., Morgan, G., Armitage, R. J., Kinnon, C., Minty, A., Grabstein, K. H., Caput, D., Ferrara, P., Callard, T. (1995) Function of the interleukin-2 (IL-2) receptor γ-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 85, 38-42.
29. McNiece, I. K., Langley, K. E., Zsebo, K. M. (1991) The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL-7. J. Immunol. 146, 3785-3790.
30. Billips, L. G., Petitte, D., Dorshkind, K., Narayanan, R., Chiu, C. P., Landreth, K. S. (1992) Differential roles of stromal cells, interleukin-7, and kit-ligand in the regulation of B lymphopoiesis. Blood 79, 1185-1192.
31. Conley, M. E., Broides, A., Hernandez-Trujillo, V., Howard, V., Kanegane, H., Miyawaki, T., Shurtleff, S. A. (2005) Genetic analysis of patients with defects in early B-cell development. Immunol. Rev. 203, 216-234.
32. Smith, C. I., Islam, T. C., Mattsson, P. T., Mohamed, A. J., Nore, B. F., Vihinen, M. (2001) The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays 23, 436-446.
33. Gomez-Rodriguez, J., Readinger, J. A., Viorritto, I. C., Mueller, K. L., Houghtling, R. A., Schwartzberg, P. L. (2007) Tec kinases, actin, and cell adhesion. Immunol. Rev. 218, 45-64.
34. Mohamed, A. J., Nore, B. F., Christensson, B., Smith, C. I. (1999) Signalling of Bruton's tyrosine kinase, Btk. Scand. J. Immunol. 49, 113-118.
35. Satterthwaite, A. B., Witte, O. N. (2000) The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol. Rev. 175, 120-127.
36. Hyvonen, M., Saraste, M. (1997) Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia. EMBO J. 16, 3396-3404.
37. Varnai, P., Rother, K. I., Balla, T. (1999) Phosphatidylinositol 3-kinasedependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells. J. Biol. Chem. 274, 10983-10989.
38. Saito, K., Scharenberg, A. M., Kinet, J. P. (2001) Interaction between the Btk PH domain and phosphatidylinositol-3,4,5-trisphosphate directly regulates Btk. J. Biol. Chem. 276, 16201-16206.
39. Mohamed, A. J., Yu, L., Backesjo, C. M., Vargas, L., Faryal, R., Aints, A., Christensson, B., Berglof, A., Vihinen, M., Nore, B. F., Smith, C. I. (2009) Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain. Immunol. Rev. 228, 58-73.
40. Huang, K. C., Cheng, H. T., Pai, M. T., Tzeng, S. R., Cheng, J. W. (2006) Solution structure and phosphopeptide binding of the SH2 domain from the human Bruton's tyrosine kinase. J. Biomol. NMR 36, 73-78.
41. Hansson, H., Mattsson, P. T., Allard, P., Haapaniemi, P., Vihinen, M., Smith, C. I., Hard, T. (1998) Solution structure of the SH3 domain from Bruton's tyrosine kinase. Biochemistry 37, 2912-2924.
42. Mao, C., Zhou, M., Uckun, F. M. (2001) Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia. J. Biol. Chem. 276, 41435-41443.
43. Samelson, L. E. (2011) Immunoreceptor signaling. Cold Spring Harb. Perspect. Biol. 3, 1-3.
44. Joseph, R. E., Min, L., Xu, R., Musselman, E. D., Andreotti, A. H. (2007) A remote substrate docking mechanism for the tec family tyrosine kinases. Biochemistry 46, 5595-5603.
45. Wu, J. N., Koretzky, G. A. (2004) The SLP-76 family of adapter proteins. Semin. Immunol. 16, 379-393.
46. Spaargaren, M., Beuling, E. A., Rurup, M. L., Meijer, H. P., Klok, M. D., Middendorp, S., Hendriks, R. W., Pals, S. T. (2003) The B cell antigen receptor controls integrin activity through Btk and PLCγ2. J. Exp. Med. 198, 1539-1550.
47. Adachi, T., Alam, R. (1998) The mechanism of IL-5 signal transduction. Am. J. Physiol. 275, C623-C633.
48. Marron, T. U., Martinez-Gallo, M., Yu, J. E., Cunningham-Rundles, C. (2012) Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines. J. Allergy Clin. Immunol. 129, 184-190. e1-4.
49. Mukhopadhyay, S., Mohanty, M., Mangla, A., George, A., Bal, V., Rath, S., Ravindran, B. (2002) Macrophage effector functions controlled by Bruton's tyrosine kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance. J. Immunol. 168, 2914-2921.
50. Schmidt, N. W., Thieu, V. T., Mann, B. A., Ahyi, A. N., Kaplan, M. H. (2006) Bruton's tyrosine kinase is required for TLR-induced IL-10 production. J. Immunol. 177, 7203-7210.
51. Hasan, M., Lopez-Herrera, G., Blomberg, K. E., Lindvall, J. M., Berglof, A., Smith, C. I., Vargas, L. (2008) Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice. Immunology 123, 239-249.
52. Doyle, S. L., Jefferies, C. A., Feighery, C., O'Neill, L. A. (2007) Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase. J. Biol. Chem. 282, 36953-36960.
53. Jefferies, C. A., Doyle, S., Brunner, C., Dunne, A., Brint, E., Wietek, C., Walch, E., Wirth, T., O'Neill, L. A. (2003) Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor κB activation by Toll-like receptor 4. J. Biol. Chem. 278, 26258-26264.
54. Fiedler, K., Kokai, E., Bresch, S., Brunner, C. (2013) MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen. Am. J. Blood Res. 3,124-140.
55. Mansell, A., Smith, R., Doyle, S. L., Gray, P., Fenner, J. E., Crack, P. J., Nicholson, S. E., Hilton, D. J., O'Neill, L. A., Hertzog, P. J. (2006) Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7, 148-155.
56. Horwood, N. J., Mahon, T., McDaid, J. P., Campbell, J., Mano, H., Brennan, F. M., Webster, D., Foxwell, B. M. (2003) Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor α production. J. Exp. Med. 197, 1603-1611.
57. Horwood, N. J., Page, T. H., McDaid, J. P., Palmer, C. D., Campbell, J., Mahon, T., Brennan, F. M., Webster, D., Foxwell, B. M. (2006) Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J. Immunol. 176, 3635-3641.
58. Sochorova, K., Horvath, R., Rozkova, D., Litzman, J., Bartunkova, J., Sediva, A., Spisek, R. (2007) Impaired Toll-like receptor 8-mediated IL-6 and TNF-α production in antigen-presenting cells from patients with X-linked agammaglobulinemia. Blood 109, 2553-2556.
59. Taneichi, H., Kanegane, H., Sira, M. M., Futatani, T., Agematsu, K., Sako, M., Kaneko, H., Kondo, N., Kaisho, T., Miyawaki, T. (2008) Tolllike receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia. Clin. Immunol. 126, 148-154.
60. Marron, T. U., Rohr, K., Martinez-Gallo, M., Yu, J., Cunningham-Rundles, C. (2010) TLR signaling and effector functions are intact in XLA neutrophils. Clin. Immunol. 137, 74-80.
61. Honda, F., Kano, H., Kanegane, H., Nonoyama, S., Kim, E. S., Lee, S. K., Takagi, M., Mizutani, S., Morio, T. (2012) The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils. Nat. Immunol. 13, 369-378.
62. Fiedler, K., Sindrilaru, A., Terszowski, G., Kokai, E., Feyerabend, T. B., Bullinger, L., Rodewald, H. R., Brunner, C. (2011) Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia. Blood 117, 1329-1339.
63. Aghamohammadi, A., Cheraghi, T., Rezaei, N., Kanegane, H., Abdollahzede, S., Talaei-Khoei, M., Heidari, G., Zandieh, F., Moin, M., Miyawaki, T. (2009) Neutropenia associated with X-linked agammaglobu-linemia in an Iranian referral center. Iran J. Allergy Asthma Immunol. 8, 43-47.
64. Krupa, A., Fudala, R., Florence, J., M., Tucker, T., Allen, T. C., Standiford, T. J., Luchowski, R., Fol, M., Rahman, M., Gryczynski, Z., Gryczynski, I., Kurdowska, A. K. (2013) Bruton's tyrosine kinase mediates FcγRIIa/Toll-like receptor-4 receptor crosstalk in human neutrophils. Am. J. Respir. Cell Mol. Biol. 48, 240-249.
65. Cariappa, A., Kim, T. J., Pillai, S. (1999) Accelerated emigration of B lymphocytes in the Xid mouse. J. Immunol. 162, 4417-4423.
66. De Gorter, D. J., Beuling, E. A., Kersseboom, R., Middendorp, S., van Gils, J. M., Hendriks, R. W., Pals, S. T., Spaargaren, M. (2007) Bruton's tyrosine kinase and phospholipase Cγ2 mediate chemokine-controlled B cell migration and homing. Immunity 26, 93-104.
67. Gilbert, C., Levasseur, S., Desaulniers, P., Dusseault, A. A., Thibault, N., Bourgoin, S. G., Naccache, P. H. (2003) Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. II. Effects of LFM-A13, a specific Btk inhibitor. J. Immunol. 170, 5235-5243.
68. Lachance, G., Levasseur, S., Naccache, P. H. (2002) Chemotactic factorinduced recruitment and activation of Tec family kinases in human neutrophils. Implication of phosphatidylinositol 3-kinases. J. Biol. Chem. 277, 21537-21541.
69. Mueller, H., Stadtmann, A., Van Aken, H., Hirsch, E., Wang, D., Ley, K., Zarbock, A. (2010) Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) γ2 and PI3Kγ pathways. Blood 115, 3118-3127.
70. Block, H., Herter, J. M., Rossaint, J., Stadtmann, A., Kliche, S., Lowell, C. A., Zarbock, A. (2012) Crucial role of SLP-76 and ADAP for neutrophil recruitment in mouse kidney ischemia-reperfusion injury. J. Exp. Med. 209, 407-421.
71. Kuehn, H. S., Radinger, M., Brown, J. M., Ali, K., Vanhaesebroeck, B., Beaven, M. A., Metcalfe, D. D., Gilfillan, A. M. (2010) Btk-dependent Rac activation and actin rearrangement following Fc∈RI aggregation promotes enhanced chemotactic responses of mast cells. J. Cell Sci. 123, 2576-2585.
72. Block, H., Zarbock, A. (2012) The role of the tec kinase Bruton's tyrosine kinase (Btk) in leukocyte recruitment. Int. Rev. Immunol. 31, 104-118.
73. Gagliardi, M. C., Finocchi, A., Orlandi, P., Cursi, L., Cancrini, C., Moschese, V., Miyawaki, T., Rossi, P. (2003) Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function. Clin. Exp. Immunol. 133, 115-122.
74. Liu, Y., Wu, Y., Lam, K. T., Lee, P. P., Tu, W., Lau, Y. L. (2012) Dendritic and T cell response to influenza is normal in the patients with X-linked agammaglobulinemia. J. Clin. Immunol. 32, 421-429.
75. Kawakami, Y., Inagaki, N., Salek-Ardakani, S., Kitaura, J., Tanaka, H., Nagao, K., Kawakami, Y., Xiao, W., Nagai, H., Croft, M., Kawakami, T. (2006) Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3. Proc. Natl. Acad. Sci. USA 103, 153-158.
76. Kurz, S. M., Diebold, S. S., Hieronymus, T., Gust, T. C., Bartunek, P., Sachs, M., Birchmeier, W., Zenke, M. (2002) The impact of c-met/scatter factor receptor on dendritic cell migration. Eur. J. Immunol. 32, 1832-1838.
77. Adams, D. H., Harvath, L., Bottaro, D. P., Interrante, R., Catalano, G., Tanaka, Y., Strain, A., Hubscher, S. G., Shaw, S. (1994) Hepatocyte growth factor and macrophage inflammatory protein 1 β: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc. Natl. Acad. Sci. USA 91, 7144-7148.
78. Singhal, E., Kumar, P., Sen, P. (2011) A novel role for Bruton's tyrosine kinase in hepatocyte growth factor-mediated immunoregulation of dendritic cells. J. Biol. Chem. 286, 32054-32063.
79. Rock, J., Schneider, E., Grun, J. R., Grutzkau, A., Kuppers, R., Schmitz, J., Winkels, G. (2007) CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCγ2. Eur. J. Immunol. 37, 3564-3575.
80. Ho-Tin-Noe, B., Demers, M., Wagner, D., D. (2011) How platelets safeguard vascular integrity. J. Thromb. Haemost. 9, 56-65.
81. Gibbins, J. M. (2004) Platelet adhesion signalling and the regulation of thrombus formation. J. Cell Sci. 117, 3415-3425.
82. Ezumi, Y., Shindoh, K., Tsuji, M., Takayama, H. (1998) Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor γ chain complex on human platelets. J. Exp. Med. 188, 267-276.
83. Atkinson, B. T., Ellmeier, W., Watson, S. P. (2003) Tec regulates platelet activation by GPVI in the absence of Btk. Blood 102, 3592-3599.
84. Quek, L. S., Bolen, J., Watson, S. P. (1998) A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen. Curr. Biol. 8, 1137-1140.
85. Hsu, J., Gu, Y., Tan, S. L., Narula, S., Demartino, J. A., Liao, C. (2013) Bruton's tyrosine kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints. Immunol. Lett. 150, 97-104.
86. Bao, Y., Zheng, J., Han, C., Jin, J., Han, H., Liu, Y., Lau, Y. L., Tu, W., Cao, X. (2012) Tyrosine kinase Btk is required for NK cell activation. J. Biol. Chem. 287, 23769-23778.
87. Shinohara, M., Koga, T., Okamoto, K., Sakaguchi, S., Arai, K., Yasuda, H., Takai, T., Kodama, T., Morio, T., Geha, R. S., Kitamura, D., Kurosaki, T., Ellmeier, W., Takayanagi, H. (2008) Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 132, 794-806.
88. Danks, L., Workman, S., Webster, D., Horwood, N. J. (2011) Elevated cytokine production restores bone resorption by human Btk-deficient osteoclasts. J. Bone Miner. Res. 26, 182-192.
89. Lee, S. H., Kim, T., Jeong, D., Kim, N., Choi, Y. (2008) The tec family tyrosine kinase Btk regulates RANKL-induced osteoclast maturation. J. Biol. Chem. 283, 11526-11534.